CATALOGO DEI PRODOTTI DELLA RICERCA

Ciccarese, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.622
NA - Nord America 1.583
AS - Asia 1.234
SA - Sud America 142
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 5
Totale 4.604
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.561
GB - Regno Unito 634
CN - Cina 514
SG - Singapore 457
IT - Italia 183
SE - Svezia 173
IE - Irlanda 145
RU - Federazione Russa 135
HK - Hong Kong 129
BR - Brasile 127
DE - Germania 116
FR - Francia 105
FI - Finlandia 50
VN - Vietnam 46
PL - Polonia 17
NL - Olanda 16
KR - Corea 14
UA - Ucraina 13
JP - Giappone 12
MX - Messico 11
IN - India 10
TR - Turchia 10
BE - Belgio 8
CA - Canada 8
ID - Indonesia 8
AR - Argentina 7
AT - Austria 7
EC - Ecuador 6
BD - Bangladesh 5
MA - Marocco 5
EU - Europa 4
LT - Lituania 4
AZ - Azerbaigian 3
GR - Grecia 3
JO - Giordania 3
LK - Sri Lanka 3
PH - Filippine 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ES - Italia 2
HU - Ungheria 2
IQ - Iraq 2
NP - Nepal 2
TG - Togo 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
CR - Costa Rica 1
DK - Danimarca 1
GT - Guatemala 1
IL - Israele 1
KG - Kirghizistan 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
MW - Malawi 1
MY - Malesia 1
NE - Niger 1
PE - Perù 1
PK - Pakistan 1
SA - Arabia Saudita 1
SN - Senegal 1
SO - Somalia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VE - Venezuela 1
YE - Yemen 1
Totale 4.604
Salva come PNG Salva come JPEG
Città #
Southend 609
Chandler 300
Singapore 216
Dallas 170
Dublin 145
Hong Kong 129
Beijing 121
Woodbridge 105
Ashburn 93
Ann Arbor 74
Houston 54
Lawrence 46
Princeton 46
Jacksonville 44
Nanjing 42
The Dalles 39
Wilmington 38
Jinan 31
Los Angeles 30
Shenyang 26
New York 23
Verona 23
Redondo Beach 20
Columbus 19
Hebei 19
Munich 17
Buffalo 16
Changsha 15
Helsinki 15
Redwood City 14
Santa Clara 14
São Paulo 14
Tianjin 14
Dong Ket 13
Haikou 13
Milan 13
Sindelfingen 13
Zhengzhou 13
Guangzhou 12
Ho Chi Minh City 12
Seoul 10
Taizhou 10
Jiaxing 9
Bologna 8
Brussels 8
Dearborn 8
Jakarta 8
Ningbo 8
Norwalk 8
Tokyo 8
Fuzhou 7
Kent 7
Moscow 7
Nanchang 7
Seattle 7
Vienna 7
Campinas 6
Hangzhou 6
Lanzhou 6
Taiyuan 6
Brooklyn 5
Council Bluffs 5
Frankfurt am Main 5
Krakow 5
Rome 5
Turku 5
Warsaw 5
Boston 4
Bussolengo 4
Catanzaro 4
Fairfield 4
Groningen 4
Mexico City 4
Montreal 4
Phoenix 4
San Francisco 4
Trento 4
Amman 3
Athens 3
Baku 3
Betim 3
Brasília 3
Casablanca 3
Chicago 3
Colombo 3
Detroit 3
Hanoi 3
Johannesburg 3
Las Vegas 3
London 3
Manchester 3
Nave 3
Porto Alegre 3
Renton 3
Stockholm 3
Washington 3
Amsterdam 2
Ankara 2
Belo Horizonte 2
Boardman 2
Totale 2.961
Salva come PNG Salva come JPEG
Nome #
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 170
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 146
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 137
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 132
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 132
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 130
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 127
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 126
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 126
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials 123
Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier? 122
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 122
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 118
The development of PARP as a successful target for cancer therapy 114
Immunotherapy versus standard of care in metastatic renal cell carcinoma. A systematic review and meta-analysis 114
The route to personalized medicine in bladder cancer: where do we stand? 110
De novo metastatic castration sensitive prostate cancer: State of art and future perspectives 107
Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice 106
AR-V7 and prostate cancer: The watershed for treatment selection? 104
Metabolic phenotype of bladder cancer 104
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 104
2015 and human cancer: back to overall survival 103
Renal cell carcinoma in one year: Going inside the news of 2017 - A report of the main advances in RCC cancer research 101
Prostate cancer heterogeneity: Discovering novel molecular targets for therapy 100
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis 93
Metabolic alterations in renal cell carcinoma 93
Inside the 2015 ASCO Genitourinary Cancers Symposium 93
Emerging concepts on drug resistance in bladder cancer: Implications for future strategies 91
Acquired hemophagocytic syndrome: comment to the case report 91
Metabolic Alterations in Renal and Prostate Cancer 88
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma 88
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1 - kidney cancer 86
Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives 85
Cabozantinib in Advanced Renal Cell Carcinoma: Is it a METEOR? 82
New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials 81
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancer 81
Bladder cancer: molecular determinants of personalized therapy 81
Emerging Immunotargets in Bladder Cancer 77
Role of STAT3 pathway in genitourinary tumors 74
Kidney cancer and 2014: is innovation really over? 72
Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer 72
The safety and efficacy of enzalutamide in the treatment of advanced prostate cancer 69
Tp53 and its potential therapeutic role as a target in bladder cancer 66
Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis 64
The prospect of precision therapy for renal cell carcinoma 61
Present and future of personalized medicine in adult genitourinary tumors 48
PD-L1 Expression in De Novo Metastatic Castration-sensitive Prostate Cancer 43
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story 28
Totale 4.685
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.993
article - articoli 18.993
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.986
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021196 0 0 0 73 38 17 11 3 2 7 20 25
2021/2022282 15 66 2 32 23 8 3 21 10 8 11 83
2022/2023827 54 96 72 136 59 221 2 62 93 11 17 4
2023/2024357 13 34 25 32 75 36 10 39 5 18 60 10
2024/20251.019 48 54 51 234 27 37 23 20 199 47 87 192
2025/2026624 220 162 212 30 0 0 0 0 0 0 0 0
Totale 4.685